+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North America Endoscopic Retrograde Cholangiopancreatography/ERCP Market Size, Share & Industry Trends Analysis Report By Procedure, By Product, By Endotherapy Devices Type, By End User, By Country and Growth Forecast, 2022-2028

  • PDF Icon

    Report

  • 105 Pages
  • April 2022
  • Region: North America
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5600615
The North America Endoscopic Retrograde Cholangiopancreatography Market is expected to witness market growth of 7.8% CAGR during the forecast period (2022-2028).

Several ongoing studies aimed at making these endoscopic retrograde cholangiopancreatography (ECRP) devices safer to use and more efficient, as well as increased government financing for R&D, along with rising awareness of endoscopic retrograde cholangiopancreatography (ECRP) devices with their growing availability could help drive the Market growth., is projected to drive Market expansion.

For the diagnosis and treatment of pancreatobiliary system problems, endoscopic retrograde cholangiopancreatography (ERCP) equipment typically uses an integration of fluoroscopic imaging and luminal endoscopy. Percutaneous transhepatic cholangiography is a therapeutic procedure for examining the biliary channel anatomy.

North America Endoscopic Retrograde Cholangiopancreatography Market growth is attributed to extensive diagnostic imaging research and the rapid establishment of technologically advanced ERCP tools such as sphincterotomes in the region.

Increased support from regional governments for healthcare along with the presence of important firms such as Hobbs Medical Inc. in the region is encouraging Market players to bring more innovations and enhancements in Endoscopic Retrograde Cholangiopancreatography.

Due to factors such as an increase in the number of surgeries for gallbladder disease, an increase in the prevalence rate of pancreatic diseases, and high healthcare expenditure across the United States, Canada, and Mexico.

Moreover, the adoption of endoscopic retrograde cholangiopancreatography is increasing across the region due to its well-established healthcare industry and rising incidence of Acute Pancreatitis. The United States owns the majority of the Market in the North American region due to growing healthcare spending, the development of novel solutions, and population awareness.

The US Market dominated the North America Others Market by Country in 2021, and is expected to continue to be a dominant Market till 2028; thereby, achieving a Market value of $38.2 million by 2028. The Canada Market is poised to grow at a CAGR of 13.4% during (2022-2028). Additionally, The Mexico Market is expected to witness a CAGR of 13.4% during (2022-2028).

Based on Procedure, the Market is segmented into Biliary Sphincterotomy, Biliary Stenting, Biliary Dialatation, Pancreatic Sphincterotomy, and Pancreatic Duct Stenting & Dilation. Based on Product, the Market is segmented into Endotherapy Devices, Endoscopes, Visualization Systems, Energy Devices, and Others. Based on Endotherapy Devices Type, the Market is segmented into Stents & Sphincterotomes, Catheters, Lithotripter, Cannulas, Forceps, Snares, Guiding Wires, Balloons, and Others. Based on End user, the Market is segmented into Hospitals, Ambulatory Surgery Centres & Clinics, and Others. Based on countries, the Market is segmented into U.S., Mexico, Canada, and Rest of North America.

The Market research report covers the analysis of key stakeholders of the Market. Key companies profiled in the report include Olympus Corporation, Fujifilm Holdings Corporation, Ambu A/S, Boston Scientific Corporation, Steris PLC, Johnson & Johnson, B. Braun Melsungen AG, ConMed Corporation, Medtronic PLC, and Karl Storz SE & Co. KG.

Scope of the Study


Market Segments Covered in the Report:


By Procedure
  • Biliary Sphincterotomy
  • Biliary Stenting
  • Biliary Dialatation
  • Pancreatic Sphincterotomy
  • Pancreatic Duct Stenting & Dilation
By Product
  • Endotherapy Devices
    • Stents & Sphincterotomes
    • Catheters
    • Lithotripter
    • Cannulas
    • Forceps
    • Snares
    • Guiding Wires
    • Balloons
    • Others
  • Endoscopes
  • Visualization Systems
  • Energy Devices
  • Others
By End User
  • Hospitals
  • Ambulatory Surgery Centres & Clinics
  • Others

By Country
  • US
  • Canada
  • Mexico
  • Rest of North America

Key Market Players


List of Companies Profiled in the Report:

  • Olympus Corporation
  • Fujifilm Holdings Corporation
  • Ambu A/S
  • Boston Scientific Corporation
  • Steris PLC
  • Johnson & Johnson
  • Braun Melsungen AG
  • ConMed Corporation
  • Medtronic PLC
  • Karl Storz SE & Co. KG

Unique Offerings from the Publisher

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Endoscopic Retrograde Cholangiopancreatography Market, by Procedure
1.4.2 North America Endoscopic Retrograde Cholangiopancreatography Market, by Product
1.4.3 North America Endoscopic Retrograde Cholangiopancreatography Market, by End User
1.4.4 North America Endoscopic Retrograde Cholangiopancreatography Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Endoscopic Retrograde Cholangiopancreatography/ERCP Market
Chapter 4. North America Endoscopic Retrograde Cholangiopancreatography Market by Procedure
4.1 North America Biliary Sphincterotomy Market by Country
4.2 North America Biliary Stenting Market by Country
4.3 North America Biliary Dialatation Market by Country
4.4 North America Pancreatic Sphincterotomy Market by Country
4.5 North America Pancreatic Duct Stenting & Dilation Market by Country
Chapter 5. North America Endoscopic Retrograde Cholangiopancreatography Market by Product
5.1 North America Endotherapy Devices Market by Country
5.2 North America Endoscopic Retrograde Cholangiopancreatography Market by Endotherapy Devices Type
5.2.1 North America Stents & Sphincterotomes Market by Country
5.2.2 North America Catheters Market by Country
5.2.3 North America Lithotripter Market by Country
5.2.4 North America Cannulas Market by Country
5.2.5 North America Forceps Market by Country
5.2.6 North America Snares Market by Country
5.2.7 North America Guiding Wires Market by Country
5.2.8 North America Balloons Market by Country
5.2.9 North America Others Market by Country
5.3 North America Endoscopes Market by Country
5.4 North America Visualization Systems Market by Country
5.5 North America Energy Devices Market by Country
5.6 North America Others Market by Country
Chapter 6. North America Endoscopic Retrograde Cholangiopancreatography Market by End User
6.1 North America Hospitals Market by Country
6.2 North America Ambulatory Surgery Centres & Clinics Market by Country
6.3 North America Others Market by Country
Chapter 7. North America Endoscopic Retrograde Cholangiopancreatography Market by Country
7.1 US Endoscopic Retrograde Cholangiopancreatography Market
7.1.1 US Endoscopic Retrograde Cholangiopancreatography Market by Procedure
7.1.2 US Endoscopic Retrograde Cholangiopancreatography Market by Product
7.1.2.1 US Endoscopic Retrograde Cholangiopancreatography Market by Endotherapy Devices Type
7.1.3 US Endoscopic Retrograde Cholangiopancreatography Market by End User
7.2 Canada Endoscopic Retrograde Cholangiopancreatography Market
7.2.1 Canada Endoscopic Retrograde Cholangiopancreatography Market by Procedure
7.2.2 Canada Endoscopic Retrograde Cholangiopancreatography Market by Product
7.2.2.1 Canada Endoscopic Retrograde Cholangiopancreatography Market by Endotherapy Devices Type
7.2.3 Canada Endoscopic Retrograde Cholangiopancreatography Market by End User
7.3 Mexico Endoscopic Retrograde Cholangiopancreatography Market
7.3.1 Mexico Endoscopic Retrograde Cholangiopancreatography Market by Procedure
7.3.2 Mexico Endoscopic Retrograde Cholangiopancreatography Market by Product
7.3.2.1 Mexico Endoscopic Retrograde Cholangiopancreatography Market by Endotherapy Devices Type
7.3.3 Mexico Endoscopic Retrograde Cholangiopancreatography Market by End User
7.4 Rest of North America Endoscopic Retrograde Cholangiopancreatography Market
7.4.1 Rest of North America Endoscopic Retrograde Cholangiopancreatography Market by Procedure
7.4.2 Rest of North America Endoscopic Retrograde Cholangiopancreatography Market by Product
7.4.2.1 Rest of North America Endoscopic Retrograde Cholangiopancreatography Market by Endotherapy Devices Type
7.4.3 Rest of North America Endoscopic Retrograde Cholangiopancreatography Market by End User
Chapter 8. Company Profiles
8.1 Olympus Corporation
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Product Launches and Product Expansions:
8.1.5.2 Approvals and Trials:
8.2 Fujifilm Holdings Corporation
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.3 Ambu A/S
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segment & Regional Analysis
8.3.4 Recent strategies and developments:
8.3.4.1 Approvals and Trials:
8.4 Boston Scientific Corporation
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Approvals and Trials:
8.5 Steris PLC
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.6 Johnson & Johnson
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental &Regional Analysis
8.6.4 Research & Development Expenses
8.7 B. Braun Melsungen AG
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.8 ConMed Corporation
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.9 Medtronic PLC
8.9.1 Company overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.10. Karl Storz SE & Co. KG
8.10.1 Company Overview

Companies Mentioned

  • Olympus Corporation
  • Fujifilm Holdings Corporation
  • Ambu A/S
  • Boston Scientific Corporation
  • Steris PLC
  • Johnson & Johnson
  • B. Braun Melsungen AG
  • ConMed Corporation
  • Medtronic PLC
  • Karl Storz SE & Co. KG

Methodology

Loading
LOADING...